Dysferlinopathies are a group of autosomal recessive muscular dystrophies caused by pathogenic variants in the DYSF gene. While several animal...
Array
(
[id_prestablog_news] => 1874
[id_shop] => 1
[date] => 2023-05-13 00:00:00
[date_modification] => 2024-02-09 14:15:13
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[prim_key] => 3389
[id_lang] => 1
[title] => A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysf
[paragraph] => A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy
[content] => Authors
Ballouhey O, Chapoton M, Alary B, Courrier S, Da Silva N, et al,
Lab
Aix Marseille University, INSERM, Marseille, France.
Journal
Biomedicines
Abstract
Dysferlinopathies are a group of autosomal recessive muscular dystrophies caused by pathogenic variants in the DYSF gene. While several animal models of dysferlinopathy have been developed, most of them involve major disruptions of the Dysf gene locus that are not optimal for studying human dysferlinopathy, which is often caused by single nucleotide substitutions. In this study, the authors describe a new murine model of dysferlinopathy that carries a nonsense mutation in Dysf exon 32, which has been identified in several patients with dysferlinopathy. This mouse model, called Dysf p.Y1159X/p.Y1159X, displays several molecular, histological, and functional defects observed in dysferlinopathy patients and other published mouse models. This mutant mouse model is expected to be useful for testing various therapeutic approaches such as termination codon readthrough, pharmacological approaches, and exon skipping. Therefore, the data presented in this study strongly support the use of this animal model for the development of preclinical strategies for the treatment of dysferlinopathies.
BIOSEB Instruments Used
Grip strength test (BIO-GS4)
[meta_description] =>
[meta_keywords] => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216094/
[meta_title] =>
[link_rewrite] => a-dysferlin-exon-32-nonsense-mutant-mouse-model-shows-pathological-signs-of-dysferlinopathy
[actif_langue] => 1
[read] => 689
[count_comments] => 0
[id] => 1874
[categories] => Array
(
[63] => Array
(
[id_prestablog_categorie] => 63
[title] => General muscular system
[link_rewrite] => General-muscular-system
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
)
[authors] =>
[paragraph_crop] => A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy
[link_for_unique] => 1
[products_liaison] => Array
(
[48] => Array
(
[name] => Grip strength test
[description_short] => An easy way to objectively quantify the muscular strength of mice and rats, and to assess the effect of drugs, toxins, muscular (i.e. myopathy) and neurodegenerative diseases on muscular degeneration. It is widely used in conjunction with the ROTAROD motor coordination test: a normally coordinated rodent will show a decreased latency to fall off the rotating rod if its muscular strength is low. The Grip Strength Test is a must for your research on activity, motor control & coordination, and is particularly well suited for studies on Parkinson's & Huntington's disease.
New features GS4 - 2023: Color display with permanent backlight screen for easier reading, reset by footswitch, Improved battery time, Larger data memory of 500 values, Animal counter, USB port (charging/data transfer)


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://bioseb.com/en/activity-motor-control-coordination/48-grip-strength-test.html
)
)
)
1 Read more